23.47

0.45% -0.105

After Hours: 23.47

Staar Surgical Co (STAA)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Staar Surgical Co stock is traded at $23.47, with a volume of 1.94M. It is down -0.45% in the last 24 hours and down -2.69% over the past month. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Previous Close:

$23.57

Open:

$23.47

24h Volume:

1.94M

Relative Volume:

2.24

Market Cap:

$1.18B

Revenue:

$290.38M

Net Income/Loss:

$-21.03M

P/E Ratio:

-54.66

EPS:

-0.4294

Net Cash Flow:

$-54.99M

1W Performance:

+6.15%

1M Performance:

-2.69%

6M Performance:

+22.11%

1Y Performance:

-15.51%

1-Day Range:

$23.40

$24.36

1-Week Range:

$21.77

$24.36

52-Week Range:

$15.59

$35.87

Staar Surgical Co Stock (STAA) Company Profile

Name

Staar Surgical Co

Sector

Healthcare (1074)

Industry

Medical Instruments & Supplies (56)

Phone

(626) 303-7902

Address

1911 WALKER AVE, MONROVIA, CA

Employee

957

Twitter

@visianicl

Next Earnings Date

2026-08-12

Latest SEC Filings

STAA's Discussions on Twitter

Compare STAA vs ISRG, BDX, ALC, RMD, MDLN

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STAA Staar Surgical Co	23.47	1.16B	290.38M	-21.03M	-54.99M	-0.4294
ISRG Intuitive Surgical Inc	366.70	132.30B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	184.74	51.11B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	70.50	35.25B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	228.35	32.95B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	36.59	28.58B	29.14B	1.07B	1.05B	1.1956

Staar Surgical Co Stock (STAA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-09-26	Upgrade	Canaccord Genuity	Hold → Buy
Feb-03-26	Initiated	Wedbush	Neutral
Jan-16-26	Resumed	Morgan Stanley	Underweight
Apr-21-25	Initiated	Wells Fargo	Equal Weight
Feb-12-25	Downgrade	BTIG Research	Buy → Neutral
Feb-12-25	Downgrade	Jefferies	Buy → Hold
Feb-12-25	Downgrade	Mizuho	Outperform → Neutral
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy
Mar-11-24	Upgrade	Stifel	Hold → Buy
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy
Dec-08-22	Initiated	Stifel	Hold
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight
Oct-13-22	Initiated	Mizuho	Buy
Apr-08-22	Initiated	Needham	Buy
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy
Jul-09-21	Initiated	Oppenheimer	Perform
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold
Oct-26-20	Downgrade	Sidoti	Buy → Neutral
Aug-31-20	Upgrade	Sidoti	Neutral → Buy
Aug-06-20	Reiterated	The Benchmark Company	Buy
Jul-06-20	Downgrade	Sidoti	Buy → Neutral
Jun-24-20	Downgrade	BTIG Research	Buy → Neutral
Jun-15-20	Initiated	Jefferies	Buy
Dec-04-19	Initiated	BTIG Research	Buy
Sep-24-18	Reiterated	The Benchmark Company	Buy
Aug-06-18	Resumed	The Benchmark Company	Buy
Nov-20-17	Reiterated	The Benchmark Company	Buy
Aug-14-17	Reiterated	The Benchmark Company	Buy
Mar-03-17	Reiterated	The Benchmark Company	Buy
May-18-16	Upgrade	The Benchmark Company	Hold → Buy
Sep-10-13	Resumed	The Benchmark Company	Buy
Feb-28-13	Reiterated	The Benchmark Company	Buy
Nov-01-12	Downgrade	Canaccord Genuity	Buy → Hold
Mar-02-12	Initiated	Northland Securities	Outperform
Oct-25-11	Reiterated	The Benchmark Company	Buy
Oct-12-10	Initiated	Morgan Joseph	Buy
May-11-10	Initiated	Benchmark	Buy

View All

Staar Surgical Co Stock (STAA) Latest News

Aug 20, 2026

Madison Avenue Partners, LP Buys Staar Surgical Co (STAA) -- Sha - GuruFocus

Aug 20, 2026

Aug 19, 2026

STAAR (STAA) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 19, 2026

5 Insightful Analyst Questions From STAAR Surgical’s Q2 Earnings Call - Yahoo Finance

Aug 19, 2026

Aug 18, 2026

STAAR Surgical CEO Warren Foust Reports PSU Vesting and New Equity Grants on August 14, 2026 - Kalkine Media

Aug 18, 2026

STAAR Surgical (STAA) awards CFO RSUs, options and PSUs - Stock Titan

Aug 18, 2026

STAA Stock On Track For Its Fourth Straight Session Of Gains – This Analyst Would Rather Be Early Than Late On Staar’s Growth Story - Stocktwits

Aug 18, 2026

STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade - MarketBeat

Aug 17, 2026

Deciphering Staar Surgical (STAA) International Revenue Trends - Yahoo Finance

Aug 17, 2026

Stifel cuts Staar Surgical stock price target on China concerns By Investing.com - Investing.com Australia

Aug 17, 2026

Stifel cuts Staar Surgical stock price target on China concerns - Investing.com

Aug 17, 2026

Stifel Nicolaus Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $28.00 - MarketBeat

Aug 17, 2026

Staar Surgical Appoints Warren Foust as President and CEO - Eyewire+

Aug 17, 2026

STAA Maintained by Stifel -- Price Target Lowered to $28.00 - GuruFocus

Aug 17, 2026

Is STAAR Surgical (STAA) Still Below Fair Value After Its Return To Profit? - Yahoo Finance

Aug 17, 2026

Aug 16, 2026

Why STAAR Surgical (STAA) Is Up 8.1% After Returning To Profit Under New CEO Warren Foust – And What's Next - simplywall.st

Aug 16, 2026

STAA Q2 Deep Dive: China Demand and Product Expansion Drive Revenue Growth Amid Market Caution - Yahoo Finance

Aug 16, 2026

Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment - Yahoo Finance

Aug 16, 2026

STAAR Surgical (STAA) Gives Warren Foust The CEO Role After Its Profit Reset - Yahoo Finance

Aug 16, 2026

STAAR Surgical (STAA) Stock May Be 13% Below Fair Value Following Q2 Earnings Preview - Yahoo Finance

Aug 16, 2026

Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA - MarketBeat

Aug 16, 2026

Aug 14, 2026